Diagnósticos da América S.A. (BOVESPA:DASA3) agreed to acquire AmeriMed American Hospitals on January 13, 2022. The superintendent of Brazilian antitrust body Cade has approved medical diagnostic firm Dasa's acquisition of control in the Grupo Marimed hospital group, without restrictions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 BRL | +0.79% | -10.96% | -60.29% |
May. 06 | Diagnósticos da América S.A.(BOVESPA:DASA3) added to Brazil Corporate Sustainability Index | CI |
Mar. 28 | Transcript : Diagnósticos da América S.A., Q4 2023 Earnings Call, Mar 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.29% | 548M | |
+18.51% | 85.55B | |
-27.32% | 70.07B | |
+6.76% | 28.95B | |
-7.50% | 17.51B | |
+2.28% | 17.39B | |
+2.08% | 15.38B | |
+5.91% | 13.4B | |
+66.20% | 12.93B | |
+6.06% | 12.77B |
- Stock Market
- Equities
- DASA3 Stock
- News Diagnosticos da América S.A.
- Diagnósticos da América S.A. agreed to acquire AmeriMed American Hospitals.